Europe's health resilience relies on its ability to innovate

Only 4 percent of medicines shortages are related to the research-based pharmaceutical sector.

Related Keywords

Switzerland , Brazil , India , United States , China , America , , European Commission , National Medicines Verification Systems , European Centre For Disease , European Medicines Agency , North America , Critical Medicines Act , European Medicines Verification System , Medicines Directive , European Centre , Disease Control , Aid And Development , Americas , Asia , Buildings , Clinical Trials , Companies , Competitiveness , Cooperation , Data , Data Protection , Footprint , Health Systems , Hospitals , Industry , Innovation , Intellectual Property , Intelligence , Investment , Manufacturing , Markets , Medicines , Patients , Pharmacies And Pharmacists , Policy , Public Health , Regions Cohesion , Regulatory , Research , Research And Development , Resilience , Rights , Risk And Compliance , Safety , Security , Strategic Autonomy , Supply Chains , Technology , Transparency , United Kingdom , Vaccines ,